ReviewBrain communications2019
Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development.
Alicja Lerner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it